Starboard Keeps Buying Progress Software

According to a filing with the SEC from August 7th, Starboard Value owned 4.8 million shares of Progress Software Corporation (NASDAQ:PRGS), a $1.3 billion market cap company providing business operations software. The fund has now filed a new 13D which discloses that as of late October it had increased its holdings to a total of 5.6 million shares, giving it control of 8.7% of the shares outstanding. Starboard Value, managed by Jeffrey Smith, is an activist hedge fund which is estimated to have over $1 billion in assets under management. It tends to be overweight the technology sector. Starboard first crossed the 5% ownership threshold in January, when it wrote a letter to Progress’s new CEO explaining that it believed that the company was highly undervalued. It has been so bullish on the stock that it was the largest holding by market value in Starboard’s 13F portfolio at the end of June (find more top stocks from Starboard Value). The stock is down 1% year to date, however.

Jeff Smith

Earlier this month, Progress Software Corporation released its results for the company’s third fiscal quarter (which ended in August). Revenue was down 14% from the third quarter of the last fiscal year, which is roughly in line with the decline in sales that the company saw in the first half of the year. Perhaps unsurprisingly, lower revenues have led to lower margins at the software company and so in the first nine months of the fiscal year net income has been down to $11 million from $47 million in the same period a year ago. The third quarter did show a smaller decline than previous quarters, with earnings down 36%. These recent numbers aren’t great, though sell-side analysts are optimistic for the next fiscal year: despite a fairly high trailing P/E multiple, Progress trades at only 15 times forward earnings estimates.

Mariko Gordon’s Daruma Asset Management was another hedge fund that owned Progress Software Corporation at the end of the second quarter, reporting a position of 2.4 million shares (research more stocks that Daruma owned). Third Avenue Management, a fund with about $10 billion in assets under management that is run by value investor Marty Whitman, initiated a position of 1.2 million shares between April and June. See more stock picks from Third Avenue Management.

Two other smaller-cap operational software companies are Advent Software, Inc. (NASDAQ:ADVS) and Tibco Software Inc. (NASDAQ:TIBX). In their most recent quarterly report, each of these peers reported a double-digit revenue growth rate versus the same period in the previous year, and an increase in earnings as well. However, their stock prices have both declined at a double-digit rate in the last 52 weeks. They are not very attractively priced on a trailing basis, with P/E multiples greater than 30 in both cases, but as with Progress the Street is optimistic about 2013. Advent and Tibco trade at 21 and 18 times forward earnings estimates, respectively. We’re cautious about how much improvement is expected here, and even those multiples aren’t particularly attractive.

We can also compare Progress to larger enterprise software provider Oracle Corporation (NASDAQ:ORCL) and to International Business Machines Corp. (NYSE:IBM), which also offers comparable software. These larger-cap companies have much better valuations. Their trailing earnings multiples are in the 14-15 range, less than half that of any of the three smaller companies we’ve mentioned, with expected growth next year carrying Oracle to a forward P/E of 11 and IBM to a multiple of 12 times expected earnings. IBM’s earnings were flat in its most recent quarterly report versus a year ago, while Oracle’s were up 11%.

As a result, we think that Oracle and IBM are better buys than Progress or the more directly comparable software companies. In turn, Advent and Tibco are actually growing their businesses and look like better values than Progress, though we doubt that we’d recommend either in absolute terms.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!